Bethesda, Maryland Sep 26, 2024 (Issuewire.com) - ComboSpine, a medical device company revolutionizing spinal interbody fusion, today announced the appointment of two new members to its Board of Directors. Steve Healy joins as Series Seed Director, and Pete Marzano as Common Director, bringing decades of experience in the medical device industry to ComboSpine's leadership team.
ComboSpine, founded by practicing neurosurgeon Dr. Joshua Ammerman in Washington, D.C., is dedicated to making spinal fusion faster, more consistent, and more reliable. The company's flagship product, DEX360TM, is a novel, multipurpose tool designed to both prepare the spinal disc to accept a fusion implant and then deploy into the disc space as a footprint-expanding implant itself.
Steve Healy, former President of Zimmer Spine, brings over 35 years of experience in the industry. "I'm excited to join ComboSpine's board and contribute to the company's mission of improving spinal fusion outcomes," said Healy. "The DEX360 technology innovations are unique and novel approaches to disc preparation and the implant itself. The technology has the potential to offer significant advantages to both clinical outcomes and operational efficiencies.”
Peter Marzano, Vice President and Business Leader of Surgical Glaucoma at Sight Sciences and formerly in sales leadership roles at NuVasive, joins the board with a strong background in commercial leadership and business development in the spine space. “In a market that has seen significant commoditization in recent years, I was immediately drawn to ComboSpine’s innovative approach to implant design and functionality. I believe DEX360 represents a truly differentiated advancement in disc preparation and implant deployment for all spinal surgeons.” said Marzano. He further commented, “I’m honored to be part of this board and eager to leverage my experience to support the company’s commercial growth and innovation.”
Dr. Joshua Ammerman, Founder and CEO of ComboSpine, expressed enthusiasm about the new appointments: "We are thrilled to welcome Steve and Pete to our board. Their extensive experience and strategic insights will be invaluable as we work to bring DEX360 to surgeons and patients. They’re bringing an extensive network to the table will help us navigate the complexities of the orthopedic spine market, and I couldn’t think of two better professionals to influence and guide our commercial strategy."
Spencer Jones, who leads operations for ComboSpine, added, "Steve and Pete have both had success bringing innovative devices to the market by building highly effective distribution networks, and we are blessed to have them on board. Being able to lean on their combined expertise will be crucial as we scale our operations, build out distributor relationships, and positively impact patients with DEX360."
With these strategic appointments, ComboSpine is poised to accelerate its growth and innovation in the spinal surgery market. The company continues to focus on finishing development and commercializing its DEX360 technology, aiming to provide surgeons with a more efficient and effective tool for spinal fusion procedures.
About ComboSpine:
ComboSpine is a medical device company founded by Dr. Joshua Ammerman, a practicing neurosurgeon in Washington, D.C. The company is dedicated to revolutionizing spinal interbody fusion through innovative technologies like DEX360, a multipurpose tool that combines disc preparation and implant deployment in a single system. ComboSpine's mission is to make spinal fusion faster, more consistent, and more reliable, ultimately improving patient outcomes.
For more information, please contact: info@combospine.com
Media Contact
ComboSpine info@combospine.com http://www.combospine.com
